BioPlan has developed the only biofacilities database subscription that tracks over 1,600+ facilities worldwide manufacturing biopharmaceuticals. Hundreds of facilities with commercial products, many more supporting clinical production, account for well over $10 billion in equipment and consumable sales.Dec 19, 2020 · BioPharma Dive provides news and analysis for biotech and biopharmaceutical executives. We cover topics like clinical trials, drug discovery and development, pharma marketing, FDA approvals and regulations, and more.
According to present data Strongbridge Biopharma's SBBP shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). Currently there seems to be a trend where stocks in the Healthcare, Manufacturing sector(s) have been popular in this period.